Stefano retweeted
If there are no attacks on Iran over this weekend,
Gold will be +$200 on monday
Oil will probably get smashed
Stefano retweeted
🔴 MOC IMBALANCE
S&P 500: -3610.1 MLN
NASDAQ 100: -3048.4 MLN
DOW 30: -1347.1 MLN
MAG 7: -1652.0 MLN $MACRO
Stefano retweeted
$NMRA Opened a position at $0.49
Quick backstory for anyone not following this one. In Jun their lead depression drug, navacaprant, missed in its last two Phase 3 trials, making it 0-for-3, and was scrapped. The co cut about 35% of its staff, and the stock has been sold ever since... alongside the rest of small-cap biotech. It just printed a new low, and the MC sits below the $116.8M in cash it reported at Jun 30. What's left is three clinical-stage programs that the market is assigning very little value to.
Setup I'm looking at:
• Roughly $96M MC against $116.8M cash. Even after adding back ~$54M in term debt, EV is only about $33M.
• Interest-only on the debt runs through Apr 2029, so no principal comes due before the readouts.
• NMRA-511 Phase 2 moved up from Q1 2027 to year-end 2026.
Catalysts into year-end:
• NMRA-898 (M4 PAM, schizophrenia): Phase 1 MAD data in 2H 2026, covering safety, PK and CNS exposure.
• NMRA-511 (V1aR antagonist, AD agitation): higher-dose MAD cohort in healthy elderly in Q4, with Phase 2 start by year-end.
• NMRA-215 (brain-penetrant NLRP3, obesity): IND in Q4, Phase 1 by year-end.
To be clear... none of these are sure things. Early-stage programs disappoint all the time, and after Jun the market isn't giving this these guys the benefit of the doubt on any of them. That's the nature of biotech and exactly why the opportunity exists. At an EV around $33M, a lot of disappointment, IMO, is already in the price.
Just a healthy starter for now. Early-stage data rarely settles a debate on the first read, and sub-$1 puts a Nas notice on the calendar. I'd rather have room to add into the readouts than be heavy going in.
All told, this has been sold far past what the bal sheet implies. I think it starts working in anticipation of the readouts, and if they deliver, this re-rates. It lost the $1 handle in a matter of weeks on tape alone. Clean data takes it back through there quickly, and $1 is where a re-rate starts, not where it ends.
The full PL and cap structure breakdown comes once the forensic (and TA) DD wraps. Still working on it.
Anyway... just sharing my work. Check everything yourself. As always, DYOR. NFA.
Stefano retweeted
CHINESE CHIPMAKER CXMT ACHIEVES DESIGN BREAKTHROUGH IN TECHNOLOGY SOUGHT BY SAMSUNG, SK HYNIX, SCMP REPORTS
Stefano retweeted
This is CRAZY…
A bacterium discovered in the gut of a Japanese tree frog just COMPLETELY ERADICATED CANCER in 100% of treated mice after ONE DOSE.
Ewingella americana even OUTPERFORMED chemotherapy and immunotherapy in the study.
Stefano retweeted
Four months ago, I mapped🗺️ out a probable path for the semiconductor index using the legendary Jesse Livermore's theories.
Some of you might be amazed by the accuracy..others expect nothing less.
I won't burden you with the intricacies of how the process works; the technicals summarise and explain it all ..shown in the chart below.
Enjoy.
Yours truly,
The Great Martis🙏
The Philadelphia Semiconductor Index (SOX) has hit 60%+ above its 50-day moving average (MA), with this level last seen in similar extremes around March 2000 (dot-com peak).
Below, the Livermore Cylinder applies to the semiconductor index.
The question that now remains:
Where does the number 10 stop at ?
The rest is consequential.
Yours truly,
The Great Martis✨
Stefano retweeted
A stock market correction is getting pretty obvious.
Capital is going to rotate out of overcrowded AI names and flow straight into non-AI sectors like finance, retail, restaurants, healthcare, and other value plays.
Stefano retweeted
BELOW 👇 ONCHAIN analysis of $Index STOCK PAYOUTS in the last couple weeks.
@byTheGentleman If you want to get payed in stock tokens HOLD $bucket.
Payouts drop multiple times daily. So far today look at my payouts below and the day isn’t over.
The ENGINE JUST WORKS, yesterday $2482 in stocks were payed to holders. About 1800 of it was from trading activity from another RH token, more on that in my post below 👇🏾
Yes @RealBucketShop holders also get payed from the trading activities of other RH TOKENS. Read more below 👇🏾 🧵 🪡
Half Of $INDEX Holders Just Got Nothing.
The site says stocks hit your wallet every 15 minutes
On-chain there were 3 payout rounds in the last 7 days
The Oct 1 round got stuck for almost 5 days before it finished
The Oct 7 round sent $2,151 in stocks to 2,073 wallets out of 4,151 eligible
Looks like anything under 0.0005 of a share just doesn't get sent
First week of September holders got $106K in stocks
Last 7 days: $18K
1M $INDEX now earns about $20 a week
Is this still a dividend token or just a slow drip?
Stefano retweeted
Why are $bucket drops better?
Simple. We own the pools that hold all the trading activity. This allows us to return more per dollar to our holders. ✌️
Stefano retweeted
SEX or any form of ejaculation is unnatural.
Ejaculation should only occur when you want to procreate.
Stefano retweeted
The act of semen retention is a biologically active cheat code.
When you hold your seed—you are pumping this intense raw energy throughout your body.
This energy genetics heals your body. These benefits are real and there are many more, this is just scratching the surface.
Stefano retweeted
$Silver will close below its 50 DMA and therefore is headed to a retest of the July low. The drawdown in the first 5 months of this bear market was 55%, so what makes you think it won't drop to $30 by the end of it? "A multi decade breakout"? Congratulations, you've been duped.

































